My watch list  


Systematic (IUPAC) name
CAS number 443913-73-3
ATC code  ?
PubChem 3081361
Chemical data
Formula C22H24BrFN4O2 
Mol. mass 475.354 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 5 days (mean)
Excretion  ?
Therapeutic considerations
Pregnancy cat.


Legal status
Routes Oral

Vandetanib (rINN, trade name Zactima), also known as ZD6474, is a medication currently undergoing clinical trials as a potential targeted treatment for non–small-cell lung cancer. It is an antagonist of the vascular endothelial growth factor receptor (VEGFR) and the epidermal growth factor receptor (EGFR).

Vandetanib is being developed by AstraZeneca.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Vandetanib". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE